SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-001877 to SCIENTIFIC ENERGY, INC (SCGY)

SCIENTIFIC ENERGY, INC
Date: Feb. 18, 2025 · CIK: 0001276531 · Accession: 0000000000-25-001877

AI Filing Summary & Sentiment

File numbers found in text: 000-50559

Date
February 18, 2025
Author
Not clearly detected
Form
UPLOAD
Company
SCIENTIFIC ENERGY, INC

Letter

February 18, 2025 Stanley Chan Chief Executive Officer Scientific Energy, Inc. Room M 21F, Tong Nam Ah Commercial Centre 180 Alameda Dr, Carlos D'Assumpcao, Macau Re:Scientific Energy, Inc. Amendment No 2 to Form 10-K for the fiscal year ended December 31, 2023 Filed September 30, 2024 File No. 000-50559 Dear Stanley Chan: We have reviewed your filing and have the following comments. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Amendment No. 2 to Form 10-K for the Fiscal Year ended December 31, 2023 General 1.We note your response to prior comment 1. We reissue in part. Please note that each amended item of the Form 10-K must set forth the complete text of each item. Please revise your Item 1 disclosure to comply with the requirements of Rule 12b-15 of the Exchange Act. Please ensure that disclosure regarding your business operations addresses each service provided or intended to be provided by each subsidiary. Provide prominent disclosure in your company overview about the legal and operational risks associated with being based in or having the majority of the company’s operations in China, including Hong Kong and Macau. Your disclosure should make clear whether these risks could result in a material change in your operations and/or the value your securities or could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. Your disclosure should address how recent statements and regulatory actions by China’s government, such as those related to data security or anti ‐monopoly concerns, have or may 2.

February 18, 2025 Page 2 impact the company’s ability to conduct its business, accept foreign investments, or list on a U.S. or other foreign exchange. describe the significant regulatory, liquidity, and enforcement risks with cross- references to the more detailed discussion of these risks in the prospectus. For example, specifically discuss risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance notice; and the risk that the Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in your operations and/or the value of the securities you are registering for sale. Acknowledge any risks that any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ameen Hamady at 202-551-3891 or Isaac Esquivel at 202-551-3395 if you have questions regarding comments on the financial statements and related matters. Please contact Stacie Gorman at 202-551-3585 or Pam Howell at 202-551-3357 with any other questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction

Show Raw Text
February 18, 2025
Stanley Chan
Chief Executive Officer
Scientific Energy, Inc.
Room M 21F, Tong Nam Ah Commercial Centre
180 Alameda Dr, Carlos D'Assumpcao, Macau
Re:Scientific Energy, Inc.
Amendment No 2 to Form 10-K for the fiscal year ended December 31, 2023
Filed September 30, 2024
File No. 000-50559
Dear Stanley Chan:
            We have reviewed your filing and have the following comments.
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments.
Amendment No. 2 to Form 10-K for the Fiscal Year ended December 31, 2023
General
1.We note your response to prior comment 1. We reissue in part. Please note that each
amended item of the Form 10-K must set forth the complete text of each item. Please
revise your Item 1 disclosure to comply with the requirements of Rule 12b-15 of the
Exchange Act. Please ensure that disclosure regarding your business operations
addresses each service provided or intended to be provided by each subsidiary.
Provide prominent disclosure in your company overview about the legal and
operational risks associated with being based in or having the majority of the
company’s operations in China, including Hong Kong and Macau. Your disclosure
should make clear whether these risks could result in a material change in your
operations and/or the value your securities or could significantly limit or completely
hinder your ability to offer or continue to offer securities to investors and cause the
value of such securities to significantly decline or be worthless. Your disclosure
should address how recent statements and regulatory actions by China’s government,
such as those related to data security or anti ‐monopoly concerns, have or may 2.

February 18, 2025
Page 2
impact the company’s ability to conduct its business, accept foreign
investments, or list on a U.S. or other foreign exchange. describe the
significant regulatory, liquidity, and enforcement risks with cross-
references to the more detailed discussion of these risks in the
prospectus. For example, specifically discuss risks arising from the legal
system in China, including risks and uncertainties regarding the
enforcement of laws and that rules and regulations in China can change
quickly with little advance notice; and the risk that the Chinese
government may intervene or influence your operations at any time, or
may exert more control over offerings conducted overseas and/or
foreign investment in China-based issuers, which could result in a
material change in your operations and/or the value of the securities you
are registering for sale. Acknowledge any risks that any actions by the
Chinese government to exert more oversight and control over offerings
that are conducted overseas and/or foreign investment in China-based
issuers could significantly limit or completely hinder your ability to offer
or continue to offer securities to investors and cause the value of such
securities to significantly decline or be worthless.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff.
            Please contact Ameen Hamady at 202-551-3891 or Isaac Esquivel at 202-551-3395 if
you have questions regarding comments on the financial statements and related
matters. Please contact Stacie Gorman at 202-551-3585 or Pam Howell at 202-551-3357 with
any other questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction